levetiracetam

Generic: levetiracetam

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name levetiracetam
Generic Name levetiracetam
Labeler a-s medication solutions
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

levetiracetam 500 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-7368
Product ID 50090-7368_c8836786-2013-4c67-8b3c-a1c4c1ae08d0
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078993
Marketing Start 2009-01-15
Marketing End 2026-03-31

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500907368
Hyphenated Format 50090-7368

Supplemental Identifiers

RxCUI
311289
UNII
44YRR34555
NUI
N0000008486

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam (source: ndc)
Generic Name levetiracetam (source: ndc)
Application Number ANDA078993 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 120 TABLET, FILM COATED in 1 BOTTLE (50090-7368-0)
  • 60 TABLET, FILM COATED in 1 BOTTLE (50090-7368-1)
  • 90 TABLET, FILM COATED in 1 BOTTLE (50090-7368-2)
  • 180 TABLET, FILM COATED in 1 BOTTLE (50090-7368-3)
source: ndc

Packages (4)

Ingredients (1)

levetiracetam (500 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c8836786-2013-4c67-8b3c-a1c4c1ae08d0", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["311289"], "spl_set_id": ["dc455433-eabb-46f7-8486-97c8100c2bb2"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE (50090-7368-0)", "package_ndc": "50090-7368-0", "marketing_end_date": "20260331", "marketing_start_date": "20241018"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (50090-7368-1)", "package_ndc": "50090-7368-1", "marketing_end_date": "20260331", "marketing_start_date": "20241018"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-7368-2)", "package_ndc": "50090-7368-2", "marketing_end_date": "20260331", "marketing_start_date": "20241018"}, {"sample": false, "description": "180 TABLET, FILM COATED in 1 BOTTLE (50090-7368-3)", "package_ndc": "50090-7368-3", "marketing_end_date": "20260331", "marketing_start_date": "20241018"}], "brand_name": "Levetiracetam", "product_id": "50090-7368_c8836786-2013-4c67-8b3c-a1c4c1ae08d0", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "50090-7368", "generic_name": "Levetiracetam", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "500 mg/1"}], "application_number": "ANDA078993", "marketing_category": "ANDA", "marketing_end_date": "20260331", "marketing_start_date": "20090115"}